Thy3 cytology: what to do next?

Area of Science:

• Endocrinology
• Cytopathology
• Surgical Oncology

Background:

• The 'Thy' classification aids thyroid fine needle aspiration (FNA) cytology.
• Management of Thy3 classification cases presents diagnostic and therapeutic challenges.
• Thy3 subdivisions aim to clarify management but see infrequent UK adoption.

Purpose of the Study:

• Analyze Thy3 cytology management in a UK case series.
• Review literature on Thy3 classification in thyroid nodules.
• Survey UK ENT departments on Thy3 subdivision awareness and usage.

Main Methods:

• Retrospective analysis of thyroid FNA cases with Thy3 results.
• Telephone survey of UK pathology departments regarding Thy classification utilization.
• Assessment of Thy3 subdivision awareness and adoption rates.

Main Results:

• Eleven of 39 Thy3 cases (28.2%) were diagnosed with thyroid malignancy.
• Surgical intervention occurred in 24 patients; others had repeat FNA or Tru-cut biopsy.
• No surveyed departments adopted Thy3 subclassifications; only 40% were aware of them.

Conclusions:

• Thy3 FNA results indicate a substantial risk of malignancy, necessitating clear management protocols.
• Thy3 subdivisions (Thy3 (i) and Thy3 (ii)) can improve decision-making for thyroid nodules.
• Adoption of Thy3 subdivisions is recommended to streamline patient care and avoid treatment delays or unnecessary procedures.